Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.
Tebano G, Soulié C, Schneider L, Blanc C, Agher R, Seang S, Valantin MA, Palich R, Tubiana R, Peytavin G, Marcelin AG, Assoumou L, Katlama C. Tebano G, et al. Among authors: soulie c. J Antimicrob Chemother. 2020 Mar 1;75(3):675-680. doi: 10.1093/jac/dkz478. J Antimicrob Chemother. 2020. PMID: 31800056
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
Palich R, Wirden M, Peytavin G, Lê MP, Seang S, Abdi B, Schneider L, Tubiana R, Valantin MA, Paccoud O, Soulié C, Calvez V, Katlama C, Marcelin AG. Palich R, et al. Among authors: soulie c. J Antimicrob Chemother. 2020 Oct 1;75(10):2981-2985. doi: 10.1093/jac/dkaa273. J Antimicrob Chemother. 2020. PMID: 32642769
Evolution of viral quasispecies during SARS-CoV-2 infection.
Jary A, Leducq V, Malet I, Marot S, Klement-Frutos E, Teyssou E, Soulié C, Abdi B, Wirden M, Pourcher V, Caumes E, Calvez V, Burrel S, Marcelin AG, Boutolleau D. Jary A, et al. Among authors: soulie c. Clin Microbiol Infect. 2020 Nov;26(11):1560.e1-1560.e4. doi: 10.1016/j.cmi.2020.07.032. Epub 2020 Jul 24. Clin Microbiol Infect. 2020. PMID: 32717416 Free PMC article.
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen.
Palich R, Allavena C, Peytavin G, Soulie C, Tubiana R, Weiss L, Montoya Ferrer A, Duvivier C, Bouchaud O, Bottero J, Durand A, Lê MP, Marcelin AG, Dudoit Y, Assoumou L, Katlama C; ETRAL QD study group. Palich R, et al. Among authors: soulie c. J Antimicrob Chemother. 2021 Jan 19;76(2):477-481. doi: 10.1093/jac/dkaa423. J Antimicrob Chemother. 2021. PMID: 33099638 Clinical Trial.
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
Palich R, Abdi B, Wirden M, Lourida G, Tubiana R, Faycal A, Valantin MA, Schneider L, Seang S, Agher R, Simon A, Soulie C, Le MP, Peytavin G, Calvez V, Marcelin AG, Katlama C. Palich R, et al. Among authors: soulie c. J Antimicrob Chemother. 2021 Jun 18;76(7):1893-1897. doi: 10.1093/jac/dkab108. J Antimicrob Chemother. 2021. PMID: 33855355 Free article.
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
Abdi B, Lambert-Niclot S, Wirden M, Jary A, Teyssou E, Sayon S, Palich R, Tubiana R, Simon A, Valantin MA, Katlama C, Morand-Joubert L, Calvez V, Marcelin AG, Soulie C. Abdi B, et al. Among authors: soulie c. J Antimicrob Chemother. 2021 Jul 15;76(8):2148-2152. doi: 10.1093/jac/dkab123. J Antimicrob Chemother. 2021. PMID: 33930161
160 results